Safety Alert: Class II: Subpotent Drug
healthClass IIRecalled on Sep 10, 2025
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
🔢 648 vials
Sold At: Boothwyn Pharmacy LLC(U.S. Nationwide)
Recall #: FDA-DRUG-D-0609-2025
Source: FDA-ENFORCEMENT
Product Identification
- Lot/Batch Codes:
- 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
Get AI-Powered Summary
Premium members get instant insights to help you understand recalls faster
Instant 1-3 sentence summary
Quick action bullets
Clear guidance on what to do
Summary
Subpotent Drug
What to do next
- 1Stop using this product - may cause temporary or medically reversible health problems
- 2Check with retailer or manufacturer for recall status and remedy options
- 3Contact Boothwyn Pharmacy LLC for return or refund information
- 4Visit the official FDA recall page for complete details
Summaries only; always follow the official notice.